Latest news with #ALGN
Yahoo
03-05-2025
- Business
- Yahoo
Here's Why Conestoga Capital Advisors Sold Align Technology (ALGN)
Conestoga Capital Advisors, an asset management company, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equity markets started the year with a rally due to optimism about a strong economy and expectations of moderating inflation and lower interest rates. However, concerns over slowing earnings from major Technology companies, geopolitical tensions, and an upcoming announcement on tariffs led to a sharp decline in equities by the end of the first quarter. Investors sought safety, driving U.S. Treasury yields down. The Conestoga Small Cap Composite returned -11.35% (net) in the first quarter compared to the Russell 2000 Growth Index's -11.12% return. The Conestoga SMid Cap Composite returned -5.73% compared to the Russell 2500 Growth Index's -10.80% return. The Conestoga Micro-Cap Composite returned -8.24% vs the Russell Microcap Growth Index's return of -17.75%. Finally, the Conestoga Mid Cap Composite returned 0.96% (net), compared to the Russell Midcap Growth Index's -7.12% return. Please check the top 5 holdings of the fund for a better understanding of their best picks for 2025. In its first-quarter 2025 investor letter, Conestoga Capital Advisors highlighted stocks such as Align Technology, Inc. (NASDAQ:ALGN). Align Technology, Inc. (NASDAQ:ALGN) designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services. The one-month return Align Technology, Inc. (NASDAQ:ALGN) was 14.59%, and its shares lost 38.32% of their value over the last 52 weeks. On May 1, 2025, Align Technology, Inc. (NASDAQ:ALGN) stock closed at $176.74 per share with a market capitalization of $12.939 billion. Conestoga Capital Advisors stated the following regarding Align Technology, Inc. (NASDAQ:ALGN) in its Q1 2025 investor letter: "Align Technology, Inc. (NASDAQ:ALGN) is a global medical-device company that pioneered the invisible-orthodontics market with the introduction of the Invisalign® system, a clear, removable orthodontic-treatment option for straightening teeth. We have exited our position in ALGN given that revenue growth for the business has become more challenged. While ALGN remains the market share leader, it has become increasingly difficult for the company to gain additional share as new competitors have entered the market. Therefore, growth has become more captive to consumer spending cycles. The proceeds have been re-invested in higher conviction Mid Cap holdings." An orthodontist examining a patient's teeth with a intraoral scanner, demonstrating the precision of the company's technology. Align Technology, Inc. (NASDAQ:ALGN) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 58 hedge fund portfolios held Align Technology, Inc. (NASDAQ:ALGN) at the end of the fourth quarter, compared to 50 in the third quarter. While we acknowledge the potential of Align Technology, Inc. (NASDAQ:ALGN) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. In another article, we covered Align Technology, Inc. (NASDAQ:ALGN) and shared the list of high-risk stocks to buy according to billionaires. In addition, please check out our hedge fund investor letters Q1 2025 page for more investor letters from hedge funds and other leading investors. READ NEXT: Michael Burry Is Selling These Stocks and A New Dawn Is Coming to US Stocks. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
30-04-2025
- Business
- Yahoo
Align Technology: Q1 Earnings Snapshot
TEMPE, Ariz. (AP) — TEMPE, Ariz. (AP) — Align Technology Inc. (ALGN) on Wednesday reported first-quarter profit of $93.2 million. The Tempe, Arizona-based company said it had net income of $1.27 per share. Earnings, adjusted for stock option expense and pretax expenses, were $2.13 per share. The results beat Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for earnings of $1.98 per share. The maker of the Invisalign tooth-straightening system posted revenue of $979.3 million in the period, also beating Street forecasts. Six analysts surveyed by Zacks expected $972.8 million. For the current quarter ending in June, Align Technology said it expects revenue in the range of $1.05 billion to $1.07 billion. Align Technology shares have fallen 17% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $173.30, a decline of 39% in the last 12 months. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on ALGN at Sign in to access your portfolio
Yahoo
22-04-2025
- Business
- Yahoo
Align Technology price target lowered to $185 from $200 at BofA
BofA analyst Michael Ryskin lowered the firm's price target on Align Technology (ALGN) to $185 from $200 and keeps an Underperform rating on the shares. Heading into Q1 earnings, the firm trimmed volume expectations for Align given persistent end-market weakness, but took average selling prices higher to reflect reduced foreign exchange headwinds. Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today's best-performing stocks on TipRanks >> Read More on ALGN: Disclaimer & DisclosureReport an Issue Align Technology price target lowered to $249 from $272 at Morgan Stanley GOOGL, ON, ALGN: Morningstar (MORN) Names Top-Rated Stocks That Are Undervalued Align Technology announces commercial availability of Invisalign with mandibula Align Technology price target lowered to $250 from $295 at Mizuho Positive Outlook for Align Technology Amidst Stabilizing Market Share and Competitive Pressures
